Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

REMEVi vs Somi Health

By GLP-1 ScorecardUpdated

REMEViFactor scores not reassessed.
Site position #76

Higher score

Somi HealthFactor scores not reassessed.
Site position #157

Lower score

Score comparison

REMEVi has the higher recorded score — 73.5/100 to 68.7/100.

REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Before you choose

Before comparing the headline prices, the REMEVi review and the Somi Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, REMEVi vs Tablet Health and Remote Pharmacy vs Somi Health compare each of them with another graded program, and the list of alternatives to REMEVi ranks the programs closest to REMEVi on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueSomi Health +9
57
66
Dose & formulationREMEVi +8
83
75
Clinical oversightREMEVi +4
86
82
Labs & monitoringREMEVi +2
55
53
FulfillmentREMEVi +21
97
76
Contract termsREMEVi +22
69
47
REMEVi · top barSomi Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricREMEViSomi Health
WeighScore73.5/10068.7/100
GradeCC
Site position#76#157
Semaglutide$143/mo month-to-month ($96/mo on 12-month plan, $1,248 upfront; compounded)$135/mo (3-month plan; any dose; compounded)
Tirzepatide$224/mo month-to-month ($168/mo on 12-month plan, $2,184 upfront; compounded)$165/mo (3-month plan; any dose; compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
REMEVi

Site position #76 · C

Factor scores not reassessed.

Strengths

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

What to consider

  • The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Somi Health

Site position #157 · C

Factor scores not reassessed.

Strengths

  • Among the lowest compounded prices: semaglutide $135/mo, tirzepatide $165/mo (3-month plan)
  • Oral semaglutide tablet option for those who want no injections
  • One price at any dose, with the medical visit and shipping included
  • LegitScript Approved seal displayed; partnered with 503A pharmacies
  • Free 2-5 day shipping; no insurance required

What to consider

  • Compounded only - no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
  • Homepage advertises a 100% money-back guarantee but Terms state all sales are final, no refunds on medication
  • Partner pharmacies are not individually named (material transparency gap)
  • No single prescribing medical group named; only affiliated professional entities
  • State availability not published; confirmed only during intake

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard